相关实验视频
Updated: Jun 26, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
虚拟胰岛素启动是安全有效的儿童和青少年1型糖尿病
Benjamin Udoka Nwosu1,2, Margaret Pellizzari1, Maia N Pavlovic2
1Division of Endocrinology, Department of Pediatrics, Cohen Children's Medical Center, Hempstead, NY, United States.
Frontiers in clinical diabetes and healthcare
|May 15, 2024
概括
虚拟胰岛素启动对于患有1型糖尿病的年轻人来说是安全有效的. 这种方法可以增加美国少数群体获得糖尿病技术的机会.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 糖尿病 技术 技术
- 临床研究 临床研究
背景情况:
- 年轻人1型糖尿病的管理需要有效的胰岛素输送方法.
- 胰岛素治疗是血糖控制的关键技术.
- 目前的指导方针缺乏虚拟与办公室启动的对比比较.
研究的目的:
- 为了比较虚拟与办公室内胰岛素启动的安全性和有效性.
- 评估1型糖尿病儿科患者的血糖控制结果.
主要方法:
- 这是一项对112名患有1型糖尿病的儿科患者进行的纵向回顾性研究.
- 患者被分为在办公室 (n=73) 和虚拟 (n=39) 培训组.
- 血糖控制 (A1c) 的数据是在基线,开始后3个月和6个月收集的.
主要成果:
- 在0,3或6个月后,虚拟和实习组之间没有观察到A1c的显著差异.
- 在整个研究中,A1c与葡萄糖管理指标有显著的相关性.
- 在6个月后,非白人个体的A1c显著升高.
结论:
- 虚拟胰岛素启动是一种安全有效的替代方案,用于办公室培训,用于儿科1型糖尿病.
- 这种方法可以改善少数群体获得糖尿病技术的机会.
- 进一步的研究可以探索长期成果和更广泛的实施策略.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
167
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
167
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Insulin Formulations: Types and Delivery
191
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
191
Insulin: Biosynthesis, Chemistry, and Preparation
374
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
374
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K

